{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:32:48Z","timestamp":1791325968195,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":3241,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ccr.2004.07.011","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T14:24:42Z","timestamp":1095776682000},"page":"241-249","source":"Crossref","is-referenced-by-count":154,"title":["Antiapoptotic BCL-2 is required for maintenance of a model leukemia"],"prefix":"10.1016","volume":"6","author":[{"given":"Anthony","family":"Letai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia D.","family":"Sorcinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Beard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Korsmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2004.07.011_BIB1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2004.07.011_BIB2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1084\/jem.189.4.735","article-title":"Commitment to the B lymphoid lineage occurs before DH-JH recombination","volume":"189","author":"Allman","year":"1999","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.ccr.2004.07.011_BIB3","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.leu.2401573","article-title":"Expression of Bcl-2-related genes in normal and AML progenitors","volume":"13","author":"Andreeff","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2004.07.011_BIB4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0092-8674(85)80070-2","article-title":"Cloning the chromosomal breakpoint of t(14;18) human lymphomas","volume":"41","author":"Bakhshi","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB5","unstructured":"Belli, B., Deckwerth, T., Al Assaad, S., Martineau, D., Armstrong, R., Tomaselli, K., Bruncko, M., Elmore, S., Fesik, S.W., Hajduk, P., et al. (2003). A-385358, a potent BCL-XL\/BCL-2 antagonist induces apoptosis in tumor cell lines. Proc. AACR 44."},{"key":"10.1016\/j.ccr.2004.07.011_BIB6","first-page":"1036","article-title":"Small cell carcinomas of the lung express the Bcl-2 protein","volume":"145","author":"Ben-Ezra","year":"1994","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.ccr.2004.07.011_BIB7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","article-title":"BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis","volume":"8","author":"Cheng","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/22788","article-title":"Essential role for oncogenic Ras in tumour maintenance","volume":"400","author":"Chin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2004.07.011_BIB9","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.82.21.7439","article-title":"Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18","volume":"82","author":"Cleary","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2004.07.011_BIB10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","article-title":"Cell death","volume":"116","author":"Danial","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1097-2765(00)80367-6","article-title":"Reversible tumorigenesis by MYC in hematopoietic lineages","volume":"4","author":"Felsher","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB12","first-page":"1089","article-title":"Expression of the bcl-2 gene product in follicular lymphoma","volume":"140","author":"Gaulard","year":"1992","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.ccr.2004.07.011_BIB13","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1073\/pnas.85.22.8548","article-title":"Evolution of B-cell malignancy","volume":"85","author":"Gauwerky","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2004.07.011_BIB14","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1126\/science.7792603","article-title":"Transcriptional activation by tetracyclines in mammalian cells","volume":"268","author":"Gossen","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ccr.2004.07.011_BIB15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(02)00024-7","article-title":"A matter of life and death","volume":"1","author":"Green","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1101\/gad.1051603","article-title":"Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis","volume":"17","author":"Gunther","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.ccr.2004.07.011_BIB17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB18","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.leu.2401168","article-title":"Expression of Bcl-2 family of proteins in fresh myeloma cells","volume":"12","author":"Harada","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2004.07.011_BIB19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","article-title":"B cell development pathways","volume":"19","author":"Hardy","year":"2001","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.ccr.2004.07.011_BIB20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.278.5340.1064","article-title":"Integrating genetic approaches into the discovery of anticancer drugs","volume":"278","author":"Hartwell","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ccr.2004.07.011_BIB21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jcb.240590407","article-title":"Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system","volume":"59","author":"Hennighausen","year":"1995","journal-title":"J. Cell. Biochem"},{"key":"10.1016\/j.ccr.2004.07.011_BIB22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/348334a0","article-title":"Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death","volume":"348","author":"Hockenbery","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2004.07.011_BIB23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/71691","article-title":"Reversibility of acute B-cell leukaemia induced by BCR-ABL1","volume":"24","author":"Huettner","year":"2000","journal-title":"Nat. Genet"},{"key":"10.1016\/j.ccr.2004.07.011_BIB24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.cdd.4401211","article-title":"c-Myc induces cytochrome c release in Rat1 fibroblasts by increasing outer mitochondrial membrane permeability in a Bid-dependent manner","volume":"10","author":"Iaccarino","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ccr.2004.07.011_BIB25","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1021\/bi002368e","article-title":"Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand, antimycin A","volume":"40","author":"Kim","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ccr.2004.07.011_BIB26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s004030050479","article-title":"Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma","volume":"292","author":"Leiter","year":"2000","journal-title":"Arch. Dermatol. Res"},{"key":"10.1016\/j.ccr.2004.07.011_BIB27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","article-title":"Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics","volume":"2","author":"Letai","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(92)90611-F","article-title":"Targeted mutation of the DNA methyltransferase gene results in embryonic lethality","volume":"69","author":"Li","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2004.07.011_BIB31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(89)90174-8","article-title":"bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation","volume":"57","author":"McDonnell","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1097-2765(00)80350-0","article-title":"Reversible activation of c-Myc in skin","volume":"3","author":"Pelengaris","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB33","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood.V79.11.2981.2981","article-title":"Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells","volume":"79","author":"Schena","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.07.011_BIB34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc1044","article-title":"Senescence, apoptosis and therapy\u2014cutting the lifelines of cancer","volume":"3","author":"Schmitt","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2004.07.011_BIB35","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/79542","article-title":"Genetic analysis of chemoresistance in primary murine lymphomas","volume":"6","author":"Schmitt","year":"2000","journal-title":"Nat. Med"},{"key":"10.1016\/j.ccr.2004.07.011_BIB36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/348331a0","article-title":"Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2","volume":"348","author":"Strasser","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2004.07.011_BIB37","first-page":"1","article-title":"E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells","volume":"8","author":"Strasser","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2004.07.011_BIB38","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.ccr.2004.07.011_BIB39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35055095","article-title":"Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3","volume":"3","author":"Tzung","year":"2001","journal-title":"Nat. Cell Biol"},{"key":"10.1016\/j.ccr.2004.07.011_BIB40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes haemopoietic cell survival and cooperates with c- myc to immortalize pre-B cells","volume":"335","author":"Vaux","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2004.07.011_BIB41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(93)80065-M","article-title":"Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair","volume":"75","author":"Veis","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.07.011_BIB42","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.97.13.7124","article-title":"Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells","volume":"97","author":"Wang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2004.07.011_BIB43","first-page":"1498","article-title":"Cell permeable Bcl-2 binding peptides","volume":"60","author":"Wang","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ccr.2004.07.011_BIB44","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2000.18.9.1812","article-title":"Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma","volume":"18","author":"Waters","year":"2000","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.ccr.2004.07.011_BIB45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK","volume":"292","author":"Wei","year":"2001","journal-title":"Science"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610804002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610804002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T01:26:49Z","timestamp":1585877209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610804002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1535610804002181"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2004.07.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1022062.251666","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}